EVOLUS, INC. Tax Withholding Paid on Stock Awards
EVOLUS, INC. (EOLS) reported Tax Withholding Paid on Stock Awards of $0 for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-05-04
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-03-31 was $8.00K.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2024-03-31 was $0.00.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $990.00K, a 14042.86% increase from fiscal 2023.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $7.00K.
- EVOLUS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-03 | |||
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-04 | |||
| 2024-12-31 | $990.00K 10-K · filed 2026-03-03 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $7.00K 10-K · filed 2026-03-03 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-04 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2019-03-31 | $58.00K 10-Q · filed 2020-05-11 | $58.00K derived: sum of 2 quarters · filed 2020-05-11 | $58.00K derived: sum of 3 quarters · filed 2020-05-11 | $297.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $0.00 derived: sum of 2 quarters · filed 2019-03-20 | $239.00K derived: sum of 3 quarters · filed 2019-03-20 | $239.00K 10-K · filed 2019-03-20 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $239.00K derived: sum of 2 quarters · filed 2018-11-05 | $239.00K 10-Q · filed 2018-11-05 | $239.00K derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-06-30 | $239.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $239.00K 10-Q · filed 2018-08-02 | $239.00K derived: sum of 3 quarters · filed 2019-05-01 | $239.00K derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2019-05-01 | $0.00 derived: sum of 3 quarters · filed 2019-05-01 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $0.00 derived: sum of 2 quarters · filed 2019-03-20 | $0.00 10-K · filed 2019-03-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |